Dhanushi Rupasinghe at IAS 2023. Photo by Roger Pebody/AidsmapIntegrase inhibitors increase the risk of developing type 2 diabetes regardless of how much weight is gained while taking one, a large international cohort study has found.
People with HIV taking an integrase inhibitor as part of their HIV treatment had a 48% higher risk of developing type 2 diabetes. More research is needed to understand the mechanism that raises diabetes risk in people taking integrase inihibitors, say researchers who carried out an international cohort study to look at the relationship between HIV treatment, weight gain and diabetes.
Read the full story at Aidsmap.
Source : Aidsmap
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.